Our Anti-Retinoic Acid Receptor, α-Isotype primary antibody from PhosphoSolutions is mouse monoclonal. It detects human, mouse and rat Retinoic Acid Receptor, α-Isotype and is Protein G purified. It is great for use in WB.
Western blot of rat hippocampal lysate showing specific immunolabeling of the ~48 kDa RAR-α protein.
Anti-Retinoic Acid Receptor, α-Isotype Antibody
Retinoic Acid Receptor, α-Isotype
Retinoic acid (RA; active metabolite of vitamin A) plays a prominent role in regulating the transition of proliferating precursor cells (such as carcinoma cells and neuronal precursors) to postmitotic differentiated cells (Joshi et al., 2005). The retinoid X receptors (RXRs) family (RXRα, β and γ), preferentially bind 9-cis-RA and regulate gene transcription by forming heterodimers with a second family of RA receptors. RAs have been suggested to potentially play a therapeutic role in cervical cancer (Abu et al., 2005). RAs are known to play key roles in neuronal development and an increasing body of evidence indicates that retinoid signaling may regulate synaptic plasticity and associated learning and memory behaviors (Lane and Bailey, 2005).
Protein G Purified
Synthetic peptide corresponding to amino acid residues from the N-terminal region of human retinoic acie receptor, α-isotype, conjugated to keyhole limpet hemocyanin (KLH).
Storage at -20°C is recommended, as aliquots may be taken without freeze/thawing due to presence of 50% glycerol. Stable for at least 1 year at -20°C.
Prepared from tissue culture supernatant by ammonium sulfate precipitation followed by purification on a Protein G column.
10 mM HEPES (pH 7.5), 150 mM NaCl, 100 µg per ml BSA and 50% glycerol.
WB Brain: 1:1000
Specific for endogenous levels of the ~48 kDa RAR-α isotype.
Western blots performed on each lot.
For research use only. Not intended for therapeutic or diagnostic use. Use of all products is subject to our terms and conditions, which can be viewed on our website.
After date of receipt, stable for at least 1 year at -20°C.
NR1B1 antibody, Nuclear mitotic apparatus protein retinoic acid receptor alpha fusion protein antibody, Nuclear receptor subfamily 1 group B member 1 antibody, Nucleophosmin retinoic acid receptor alpha fusion protein NPM RAR long form antibody, RAR alpha antibody, RAR antibody, RAR-alpha antibody, rara antibody, RARA_HUMAN antibody, RARalpha antibody, RARalpha1 antibody, Retinoic acid nuclear receptor alpha variant 1 antibody, Retinoic acid nuclear receptor alpha variant 2 antibody, Retinoic acid receptor alpha antibody, Retinoic acid receptor alpha polypeptide antibody
Abu, J., Batuwangala, M., Herbert, K. and Symonds, P., 2005. Retinoic acid and retinoid receptors: potential chemopreventive and therapeutic role in cervical cancer. The Lancet Oncology, 6(9), pp.712-720. PMID: 16129372
Joshi, S., Guleria, R., Pan, J., DiPette, D. and Singh, U.S., 2006. Retinoic acid receptors and tissue-transglutaminase mediate short-term effect of retinoic acid on migration and invasion of neuroblastoma SH-SY5Y cells. Oncogene, 25(2), p.240. PMID: 16158052
Lane, M.A. and Bailey, S.J., 2005. Role of retinoid signalling in the adult brain. Progress in Neurobiology, 75(4), pp.275-293. PMID: 15882777
You may also like
We stand by what we sell.
We are proud of every product that leaves our lab.
Support from the source.
No one knows our products like us, and we want you to succeed.